{"id":"W6976907216","doi":"10.6084/m9.figshare.13154069.v1","title":"Metadata record for the manuscript: Glembatumumab vedotin for patients with metastatic, gpNMB over-expressing, triplenegative breast cancer (“METRIC”): A Randomized Multicenter Study","year":2021,"lang":"en","type":"dataset","venue":"Figshare","topic":"Linguistic research and analysis","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Capecitabine; Metadata; Table (database); Clinical trial; Multicenter study; Declaration; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01038668,0.001038673,0.00262496,0.003519801,0.001703675,0.007416786,0.002444619,0.003795343,0.7142374],"category_scores_gemma":[0.09952924,0.001321125,0.00269887,0.006162651,0.0009411505,0.005551244,0.002484918,0.002723784,0.317589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002751935,"about_ca_system_score_gemma":0.01126925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003895396,"about_ca_topic_score_gemma":0.008825275,"domain_scores_codex":[0.9907816,0.002141424,0.003742755,0.0006812331,0.002207633,0.0004452937],"domain_scores_gemma":[0.9039444,0.03708956,0.01588035,0.01205243,0.02608514,0.004948074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.00124296,0.00006853498,0.0006730834,0.0064422,0.00009612897,0.00003813891,0.00004109286,0.0000866608,0.0003307828,0.001311123,0.9669999,0.02266941],"study_design_scores_gemma":[0.006844192,0.0005665923,0.004899608,0.006740824,0.0003108952,0.0002578479,0.000185994,0.0002610907,0.001222296,0.004031061,0.9745499,0.0001296722],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.0005991563,0.0008964497,0.001263259,0.008205513,0.00203402,0.004639886,0.9543428,0.001761865,0.02625703],"genre_scores_gemma":[0.01056135,0.003633535,0.0123399,0.01323991,0.003261615,0.02076977,0.8490629,0.003269656,0.08386137],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.7142374,"threshold_uncertainty_score":0.4076056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06788925672450688,"score_gpt":0.320602971018337,"score_spread":0.25271371429383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}